Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

485
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
485
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

762
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
762
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

1.9K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

630
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
630
Angina II: Classification01:27

Angina II: Classification

692
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
692
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

477
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
477

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular mechanisms of coronary microembolization-induced MINOCA.

Basic research in cardiology·2026
Same author

Realizing the full potential of registry-based randomized controlled trials.

Journal of clinical epidemiology·2026
Same author

Authors' reply: Poor long-term cardiovascular risk factor management after acute coronary syndrome: An observational cohort study.

Journal of internal medicine·2026
Same author

Mental disorders, psychotropic drug dispensation and unfavourable sociodemographic factors in patients with myocardial infarction with and without obstructive coronary arteries.

International journal of cardiology. Cardiovascular risk and prevention·2026
Same author

Poor long-term cardiovascular risk factor management after acute coronary syndrome: An observational cohort study.

Journal of internal medicine·2026
Same author

Helicobacter pylori, Inflammation, and Long-Term Outcome in Patients With Acute Myocardial Infarction: A Prospective Cohort Study.

Helicobacter·2026

Related Experiment Video

Updated: Apr 21, 2026

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
11:17

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

Published on: November 28, 2025

536

Type 2 myocardial infarction in clinical practice.

Tomasz Baron1, Kristina Hambraeus2, Johan Sundström1

  • 1Department of Medical Sciences, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

Heart (British Cardiac Society)
|October 22, 2014
PubMed
Summary

Type 2 acute myocardial infarction (AMI) affects 7.1% of patients and is more common in older women with comorbidities. While crude mortality is higher, adjusted 1-year mortality for type 2 AMI is similar to type 1 AMI.

Keywords:
MYOCARDIAL ISCHAEMIA AND INFARCTION (IHD)

More Related Videos

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

29.5K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

23.8K

Related Experiment Videos

Last Updated: Apr 21, 2026

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
11:17

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

Published on: November 28, 2025

536
Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

29.5K
A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

23.8K

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Public Health

Background:

  • Acute myocardial infarction (AMI) classification is crucial for understanding disease subtypes.
  • Type 1 AMI results from plaque rupture, while Type 2 AMI is due to oxygen supply-demand mismatch.
  • Differences in incidence, clinical presentation, and outcomes between Type 1 and Type 2 AMI require investigation.

Purpose of the Study:

  • To compare the incidence, clinical features, treatment strategies, and outcomes of Type 2 AMI versus Type 1 AMI.
  • To identify patient characteristics associated with Type 2 AMI.
  • To evaluate the impact of treatment variations on mortality in Type 2 AMI.

Main Methods:

  • Retrospective analysis of 20,138 hospitalizations for AMI in Sweden during 2011.
  • Classification of AMI cases into types 1-5 based on the 2007 universal definition of myocardial infarction.
  • Comparison of patient demographics, comorbidities, treatment, and 1-year mortality between Type 1 and Type 2 AMI groups.

Main Results:

  • Type 2 AMI accounted for 7.1% of all AMIs, with Type 1 comprising 88.5%.
  • Patients with Type 2 AMI were older, more frequently female, and had higher rates of comorbidities, renal dysfunction, and anemia.
  • Type 2 AMI patients showed less invasive treatment and antiplatelet use, with higher crude 1-year mortality (24.7% vs. 13.5%).

Conclusions:

  • Type 2 AMI represents a significant proportion of myocardial infarctions, characterized by distinct patient demographics and comorbidities.
  • Less aggressive treatment strategies were observed in Type 2 AMI patients.
  • While crude mortality was higher in Type 2 AMI, adjusted 1-year mortality was similar to Type 1 AMI, suggesting similar long-term prognosis after accounting for patient factors.